- Report
- June 2025
- 268 Pages
Global
From €5255EUR$5,850USD£4,487GBP
- Report
- June 2025
- 193 Pages
Global
From €5255EUR$5,850USD£4,487GBP
- Report
- June 2025
- 292 Pages
Global
From €5255EUR$5,850USD£4,487GBP
- Report
- June 2025
- 554 Pages
Global
From €5255EUR$5,850USD£4,487GBP
- Report
- June 2025
- 172 Pages
Global
From €5255EUR$5,850USD£4,487GBP
- Report
- June 2025
- 72 Pages
Global
From €5255EUR$5,850USD£4,487GBP
- Report
- June 2025
- 63 Pages
Global
From €5255EUR$5,850USD£4,487GBP
- Report
- June 2025
- 380 Pages
Global
From €5255EUR$5,850USD£4,487GBP
- Report
- June 2025
- 372 Pages
Global
From €5255EUR$5,850USD£4,487GBP
- Report
- June 2025
- 367 Pages
Global
From €5255EUR$5,850USD£4,487GBP
- Report
- June 2025
- 73 Pages
Global
From €5255EUR$5,850USD£4,487GBP
- Report
- June 2025
- 108 Pages
Global
From €5255EUR$5,850USD£4,487GBP
- Report
- June 2025
- 262 Pages
Global
From €5255EUR$5,850USD£4,487GBP
- Report
- June 2025
- 103 Pages
Global
From €5255EUR$5,850USD£4,487GBP
- Report
- June 2025
- 89 Pages
Global
From €5255EUR$5,850USD£4,487GBP
- Report
- June 2025
- 89 Pages
Global
From €5255EUR$5,850USD£4,487GBP
- Report
- June 2025
- 93 Pages
Global
From €5255EUR$5,850USD£4,487GBP
- Report
- June 2025
- 274 Pages
Global
From €5255EUR$5,850USD£4,487GBP
- Report
- June 2025
- 334 Pages
Global
From €5255EUR$5,850USD£4,487GBP
- Report
- June 2025
- 403 Pages
Global
From €5255EUR$5,850USD£4,487GBP

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more